TO review and evaluate research on pharmaceutical services in community and ambulatory care pharmacy settings, specifically study designs and patient outcome measures, and to provide recommendations to improve future research on pharmaceutical services in community and ambulatory care pharmacy settings.
DATA SOURCE:
English-language articles were identified by searching MEDLINE (1966-December 1998) and International Pharmaceutical Abstracts (1970-December 1998), using a combination of search terms: pharmacist services, pharmacist interventions, community pharmacy, ambulatory care, primary care, and patient outcomes. Relevant studies were selected based on article abstracts.
DATA EXTRACTION:
From each relevant study, we extracted the study objectives, sample size, study period, study design, major tasks performed by pharmacists, and economic, clinical, and humanistic outcomes (ECHO). Results were tabulated separately for research on community pharmacy and ambulatory care pharmacy settings.
RESULTS:
We identified 95 relevant studies. Of these, 21 studies were conducted in community pharmacy settings and 74 in ambulatory care settings. Ten community pharmacy studies used prospective, single group, pretest/posttest, or posttest only designs; seven used prospective two or more group comparison designs; and four used randomized, controlled designs. Nine studies on community pharmacies measured clinical outcomes, two measured humanistic outcomes, and five measured economic outcomes. Four studies measured both clinical and humanistic outcomes and one measured humanistic and economic outcomes. No study measured all three ECHO variables. Twenty-three studies in ambulatory care settings used prospective or retrospective, single group, pretest/posttest or posttest only designs; 21 used prospective or retrospective two-or-more group comparison designs; and 30 used randomized, controlled designs. Thirty-six measured clinical outcomes, five measured humanistic outcomes, and 15 measured economic outcomes. Fifteen studies measured clinical and economic outcomes and three measured clinical and humanistic outcomes.
CONCLUSIONS:
Only 21 of 95 selected studies were conducted in community pharmacy settings and measured the impact of pharmaceutical services on patient outcomes. Few studies employed adequate research designs to control threats to internal and external validity. In order to obtain a comprehensive and accurate picture of the impact of pharmaceutical services on patient outcomes, an attempt must be made to measure all three ECHO variables while employing adequate research design.
HeplerCDStrandLM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm1990;47: 533–43.
2.
MaineLLPathakDS. Measuring outcomes in contemporary pharmacy practice. In: EscovitzAPathakDS, eds. Health outcomes and pharmaceutical care: measurements, applications, and initiatives. New York: The Haworth Press, Inc., 1996: 65–79.
3.
StrandLMCipolleRJMorleyPC. Pharmaceutical care: an introduction. Kalamazoo, MI: The Upjohn Company, 1992.
4.
SchommerJCCableGL. Current status of pharmaceutical care practice: Strategies for education. Am J Pharm Ed1996;60: 36–42.
5.
HatoumHTCatizoneCHutchinsonRAPurohitA. An eleven-year review of the pharmacy literature: Documentation of the value and acceptance of clinical pharmacy. Drug Intell Clin Pharm1986;20: 33–48.
6.
KozmaCMReederCESchulzRM. Economic, clinical, and humanistic outcomes: A planning model for pharmacoeconomic research. Clin Ther1993;15: 1121–32.
7.
RuppMT. Evaluation of prescribing errors and pharmacist interventions in community practice: An estimate of ‘value added’. Am Pharm1988; NS28(12): 22–6.
8.
RuppMT. Value of community pharmacists' interventions to correct prescribing errors. Ann Pharmacother1992;26: 1580–4.
9.
FinchamJHospodkaRScottD. The true value of pharmacist care. NARD J1995;117 (3): 29–31.
10.
EvansRLKirkRFWalkerPWRosenbluthSAMcDonaldJ. Medication maintenance of mentally ill patients by a pharmacist in a community setting. Am J Hosp Pharm1976;33: 635–8.
11.
EinarsonTRBootmanJLMcGhanWFLarsonLNGardnerMEDonohueM. Establishment and evaluation of a serum cholesterol monitoring service in a community pharmacy. Drug Intell Clin Pharm1988;22: 45–8.
12.
IbrahimOMCataniaPNMergenerMASupernawRB. Outcome of cholesterol screening in a community pharmacy. DICP Ann Pharmacother1990;24: 817–21.
13.
DobieRL3rdRascatiKL. Documenting the value of pharmacist interventions. Am Pharm1994;NS34(5): 50–4.
14.
RuppMTMcCallianDJShethKK. Developing and marketing a community-based asthma management program. J Am Pharm Assoc1997; NS37: 694–9.
15.
ShibleyMCPughCB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother1997;31: 713–9.
16.
BlumlBMMcKenneyJMCzirakyMJElswickRKJr. Interim report from project IMPACT: Hyperlipidemia. J Am Pharm Assoc1998;38: 529–34.
17.
CliniteJCKabatHF. Improving patient compliance. J Am Pharm Assoc1976;NS16:74–6,85.
18.
SlamaPJGurwichEL. Effect of pharmacist consultation on medication compliance. Contemp Pharm Pract1978;1: 71–7.
19.
GotschARLiguoriS. Knowledge, attitude, and compliance dimensions of antibiotic therapy with PPIs: A community pharmacy-based study. Med Care1982;20: 581–93.
20.
MackowiakJIGagnonJP. Expectations for ambulatory services in traditional and office-practice pharmacies. Am J Hosp Pharm1984;41: 1140–6.
21.
KimberlinCLBerardoDH. A comparison of patient education methods used in community pharmacies. J Pharm Mark Manage1987;l(4): 75–94.
MunroeWPKunzKDalmady-IsraelCPotterLSchonfeldWH. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting. Clin Ther1997;19: 113–23.
24.
McKenneyJMSliningJMHendersonHRDevinsDBarrM. The effect of clinical pharmacy services on patients with essential hypertension. Circulation1973;48: 1104–11.
25.
McKenneyJMBrownDENecsaryRReavisHL. Effect of pharmacist drug monitoring and patient education on hypertensive patients. Contemp Pharm Pract1978;l(2): 50–6.
26.
McBeanBJBlackburnJL. An evaluation of four methods of pharmacist-conducted patient education. Can Pharm J1982;115: 167–72.
27.
ParkJJKellyPCarterBLBurgessPP. Comprehensive pharmaceutical care in the chain setting. J Am Pharm Assoc1996;NS36: 443–51.
28.
GurwichELSwansonLN. Clinical pharmacy practice in outpatient clinic. J Am Pharm Assoc1975;NS15: 392–9.
29.
SchillingKW. Pharmacy program for monitoring diabetic patients. Am J Hosp Pharm1977;34: 1242–5.
30.
BrownDJEllsworthATaylorJW. Identification of potentially non-compliant patients with a mailed medication refill reminder system. Contemp Pharm Pract1980;3: 244–8.
31.
SwensonJP. Training patients to administer intravenous antibiotics at home. Am J Hosp Pharm1981;38: 1480–3.
32.
SpruillWJCooperJWTaylorWJ. Pharmacist-coordinated pneumonia and influenza vaccination program. Am J Hosp Pharm1982;39: 1904–6.
33.
ScrivensJJJrMagalianPCrozierGA. Cost-effective clinical pharmacy services in a veterans administration drop-in clinic. Am J Hosp Pharm1983;40: 1952–3.
34.
ConteRRKehoeWANeilsonNLodhiaH. Nine-year experience with a pharmacist-managed anticoagulation clinic. Am J Hosp Pharm1986;43: 2460–4.
35.
KoechelerJASfierTLWilsonB. Outcome-focused counseling program for quality assurance in ambulatory care. Am J Hosp Pharm1990;47: 2020–2.
36.
HatoumHTWitteKWHutchinsonRA. Patient care contributions of clinical pharmacists in four ambulatory care clinics. Hosp Pharm1992;27: 203–6, 208–9.
37.
LobasNHLepinskiPWAbramowitzPW. Effects of pharmaceutical care on medication cost and quality of patient care in an ambulatory-care clinic. Am J Hosp Pharm1992;49: 1681–8.
38.
RadleyASHallJ. The establishment and evaluation of a pharmacist-developed anticoagulant clinic. Pharm J1994;252: 91–2.
39.
MacgregorSHHamleyJGDunbarJADoddTRCromartyJA. Evaluation of a primary care anticoagulant clinic managed by a pharmacist. BMJ1996;312: 560.
40.
WaddellJASolimandoDAJrStricklandWRSmithBDWrayMK. Pharmacy staff interventions in a medical center hematology-oncology service. J Am Pharm Assoc1998;38: 451–6.
41.
Garabedian-RuffaloSMGrayDRSaxMJRuffaloRL. Retrospective evaluation of a pharmacist-managed warfarin anticoagulation clinic. Am J Hosp Pharm1985;42: 304–8.
42.
MorseGDDouglasJBUptonJHRodgersSGalP. Effect of pharmacist intervention on control of resistant hypertension. Am J Hosp Pharm1986;43: 905–9.
43.
Ioannides-DemosLLHorneMKTongNWodakJHarrisonPMMcNeilJJImpact of a pharmacokinetics consultation service on clinical outcomes in an ambulatory-care epilepsy clinic. Am J Hosp Pharm1988;45:1549–51.
44.
HaxbyDGWeartCWGoodmanBWJr. Family practice physicians' perceptions of the usefulness of drug therapy recommendations from clinical pharmacists. Am J Hosp Pharm1988;45: 824–7.
45.
PhillipsSLCarr-LopezSM. Impact of a pharmacist on medication discontinuation in a hospital-based geriatric clinic. Am J Hosp Pharm1990;47: 1075–9.
46.
DeadyJELepinskiPWAbramowitzPW. Measuring the ability of clinical pharmacists to effect drug therapy changes in a family practice clinic using prognostic indicators. Hosp Pharm1991;26: 93–7.
47.
BorgsdorfLRManoJSKnappKK. Pharmacist-managed medication review in a managed care system. Am J Hosp Pharm1994;51: 772–7.
48.
PauleyTRMageeMJCuryJD. Pharmacist-managed, physician-directed asthma management program reduces emergency department visits. Ann Pharmacother1995;29: 5–9.
49.
RadleyASHallJFarrowMCareyPJ. Evaluation of anticoagulant control in a pharmacist operated anticoagulant clinic. J Clin Pathol1995;48: 545–7.
50.
LibbyEALaubJJ. Economic and clinical impact of a pharmacy-based antihypertensive replacement program in primary care. Am J Health-Syst Pharm1997;54: 2079–83.
51.
MaddenEEJr. Evaluation of outpatient pharmacy patient counseling. J Am Pharm Assoc1973;NS13: 437–43.
52.
LimaJNazarianLCharneyELahtiC. Compliance with short-term antimicrobial therapy: Some techniques that help. Pediatrics1976;57: 383–6.
53.
BeardsleyRSJohnsonCAWiseG. Privacy as a factor in patient counseling. J Am Pharm Assoc1977;17: 366–8.
54.
RosenCEHolmesS. Pharmacist's impact on chronic psychiatric outpatients in community mental health. Am J Hosp Pharm1978;35: 704–8.
55.
DavisS. Evaluation of pharmacist management of streptococcal throat infections in a health maintenance organization. Am J Hosp Pharm1978: 35:561–6.
56.
EdwardsRAdamsDW. Clinical pharmacy services in a pediatric ambulatory care clinic. Drug Intell Clin Pharm1982;16: 939–44.
57.
McGhanWFStimmelGLHallTGOilmanTM. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care1983;21: 435–44.
58.
CummingsDMCorsonMSeamanJJ. The effect of clinical pharmacy services provided to ambulatory care patients on hospitalization. Am J Pharm1984;56 (2): 44–50.
59.
CohenIAHutchisonTAKirkingDMShueME. Evaluation of a pharmacist-managed anticoagulation clinic. J Clin Hosp Pharm1985;10: 167–75.
60.
JonesPJGoldmanMPRockwoodRPImhoffTE. Beneficial effect of a pharmacist refill evaluation clinic. Hosp Pharm1987;22: 166–8.
61.
De TullioPLCorsonME. Effect of pharmacist counseling on ambulatory patients' use of aerosolized bronchodilators. Am J Hosp Pharm1987;44: 1802–6.
62.
ChrischillesEAHellingDKAschoffCR. Effect of clinical pharmacy services on the quality of family practice physician prescribing and medication costs. DICP Ann Pharmacother1989;23: 417–21.
63.
MasonJDColleyCA. Effectiveness of an ambulatory care clinic pharmacist: A controlled trial. Ann Pharmacother1993;27: 555–9.
64.
WiltVMGumsJGAhmedOIMooreLM. Outcome analysis of a pharmacist-managed anticoagulation service. Pharmacotherapy1995;15: 732–9.
65.
McKenneyJMWitherspoonJM. The impact of outpatient hospital pharmacists on patients receiving antihypertensive and anticoagulant therapy. Hosp Pharm1985;20: 9–11, 15,406.
66.
ForstromMJRiedLDStergachisASCorlissDA. Effect of a clinical pharmacist program on the cost of hypertension treatment in an HMO family practice clinic. DICP Ann Pharmacother1990;24: 304–9.
67.
JonesRALopezLMBeallDG. Cost-effective implementation of clinical pharmacy services in an ambulatory care clinic. Hosp Pharm1991: 26:778–82.
68.
BothaJHTyrannesIMillerRWesleyAG. Pharmacokinetic consultation program in a pediatric asthma clinic. Am J Hosp Pharm1992;49: 1936–40.
69.
NicholANicholDW. Medication management in neuropsychiatric disorders. U. S. Pharmacist1996;21 (Sep):69–70,72,74–5.
70.
EricksonSRSlaughterRHalapyH. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy1997;17: 140–7.
71.
KonzemSLGrayDRKashyapML. Effect of pharmaceutical care on optimum colestipol treatment in elderly hypercholesterolemic veterans. Pharmacotherapy1997;17: 576–83.
72.
SharpeTRMkealRL. Patient compliance with antibiotic regimens. Am J Hosp Pharm1974;31: 479–84.
73.
LinkewichJACatalanoRBHackHL. The effect of packaging and instruction on outpatient compliance with medication regimens. Drag Intell Clin Pharm1974;8: 10–5.
74.
ChubbJMWinshipHW. The pharmacist's role in preventing medication errors made by cardiac and hyperlipoproteinemic outpatients. Drag Intell Clin Pharm1974;8: 430–6.
75.
PaulsonPTBauchRPaulsonMLZilzDA. Medication data sheets: An aid to patient education. Drag Intell Clin Pharm1976;10: 448–53.
76.
GabrielMGagnonJPBryanCK. Improved patient compliance through use of a daily drag reminder chart. Am J Public Health1977;67: 968–9.
77.
SczupakCAConradWF. Relationship between patient-oriented pharmaceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am J Hosp Pharm1977;34: 1238–42.
78.
LudyJAGagnonJPCaiolaSM. The patient-pharmacist interaction in two ambulatory settings: Its relationship to patient satisfaction and drag misuse. Drag Intell Clin Pharm1977;11: 81–9.
79.
HellingDKHeplerCDJonesME. Effect of direct pharmaceutical services on patients' perception of health care quality. Am J Hosp Pharm1979;36: 325–9.
80.
HawkinsDWFiedlerFPDouglasHLEschbachRC. Evaluation of a clinical pharmacist in caring for hypertensive and diabetic patients. Am J Hosp Pharm1979;36: 1321–5.
81.
RehderTLMcCoyLKBlackwellBWhiteheadWRobinsonA. Improving medication compliance by counseling and special prescription container. Am J Hosp Pharm1980;37: 379–85.
82.
GarnettWRDavisLJMcKenneyJMSteinerKC. Effect of telephone follow-up on medication compliance. Am J Hosp Pharm1981;38: 676–9.
83.
MartinDCMeadK. Reducing medication errors in a geriatric population. J Am Geriatr Soc1982;30: 258–60.
84.
BondCAMonsonR. Sustained improvement in drug documentation, compliance, and disease control. A four-year analysis of an ambulatory care model. Arch Intern Med1984;144: 1159–62.
85.
BairdTKBroekemeierRLAndersonMW. Effectiveness of a computer-supported refill reminder system. Am J Hosp Pharm1984;41: 2395–7.
86.
AscioneFJShimpLA. The effectiveness of four education strategies in the elderly. Drag Intell Clin Pharm1984;18: 926–31.
87.
GrayDRGarabedian-RuffaloSMChretienSD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic. Drug Intell Clin Pharm1985;19: 575–80.
88.
SimkinsCVWenzloffNJ. Evaluation of a computerized reminder system in the enhancement of patient medication refill compliance. Drug Intell Clin Pharm1986;20: 799–802.
89.
De TullioPLKirkingDMArslanianCOlsonDE. Compliance measure development and assessment of theophylline therapy in ambulatory patients. J Clin Pharm Ther1987;12: 19–26.
90.
StergachisAForsMWagnerEHSimsDDPennaP. Effect of clinical pharmacists on drug prescribing in a primary-care clinic. Am J Hosp Pharm1987;44: 525–9.
91.
McKenneyJMMunroeWPWrightJTJr. Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol1992;32: 277–83.
92.
SkaerTLSclarDAMarkowskiDJWonJK. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures: A study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther1993;18: 295–9.
93.
SkaerTLSclarDAMarkowskiDJWonJK. Effect of value-added utilities on prescription refill compliance and health care expenditures for hypertension. J Hum Hypertens1993;7: 515–8.
94.
LiptonHLBirdJA. The impact of clinical pharmacists' consultation on geriatric patients' compliance and medical care use: A randomized controlled trial. Gerontologist1994;34: 307–15.
95.
HanlonJTWeinbergerMSamsaGPSchmaderKEUttechKMLewisIKA randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med1996;100:428–37.
96.
SolomonDKPortnerTSBassGEGourleyDRGourleyGAHoltJMClinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc1998;38:574–85.
97.
GourleyGAPortnerTSGourleyDRRigolosiELHoltJMSolomonDKHumanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc1998;38:586–97.
98.
CowperPAWeinbergerMHanlonJTLandsmanPBSamsaGPUttechKMThe cost-effectiveness of a clinical pharmacist intervention among elderly outpatients. Pharmacotherapy1998;18:327–32.
99.
McCombsJSLiuGShiJFengWCodyMParkerJPThe Kaiser Permanente/USC Patient Consultation Study: Change in use and cost of health care services. Am J Health-Syst Pharm1998;55:2495–9.
100.
CodyMMcCombsJSParkerJP. The Kaiser Permanente/USC Patient Consultation Study: Change in quality of life. Am J Health-Syst Pharm1998;55: 2615–20.
101.
JohnsonKAParkerJPMcCombsJSCodyM. The Kaiser Permanente/USC Patient Consultation Study: Patient satisfaction with pharmaceutical services. Am J Health-Syst Pharm1998;55: 2621–9.
102.
JangR. General purpose of research designs. Am J Hosp Pharm1980: 37:398–403.
103.
CampbellDTStanleyJC. Experimental and quasi-experimental designs for research. In: Handbook of Research on Teaching. Boston: Houghton Mifflin Company, 1963.
104.
CookTDCampbellDT. Quasi-experimentation: design and analysis issues for field settings. Boston: Houghton Mifflin Company, 1979.
105.
OdedinaFTSegalR. Behavioral pharmaceutical care scale for measuring pharmacists' activities. Am J Health-Syst Pharm1996;53: 855–65.
106.
OdedinaFTHeplerCDSegalRMillerD. The Pharmacists' Implementation of Pharmaceutical Care (PIPC) model. Pharm Res1997;14: 135–44.
107.
GupchupGVWolfgangAPThomasJ3rd. Development of a scale to measure directive guidance by pharmacists. Ann Pharmacother1996: 30:1369–75.
108.
BungayKMBoyerJGSteinwaldABWareJEJr. Health-related quality-of-life: An overview. In: BootmanJLTownsendRJMcGhanWF. Principles of pharmacoeconomics. 2nd ed. Cincinnati: Harvey Whitney Books Co., 1996: 128–49.
109.
MacKeiganLDLarsonLN. Development and validation of an instrument to measure patient satisfaction with pharmacy services. Med Care1989;27: 522–36.
110.
LarsonLNMacKeiganLD. Further validation of an instrument to measure patient satisfaction with pharmacy services. J Pharm Market Manage1994;8: 125–39.
111.
FarrisKJohnsonJSteeleN. Validation of an instrument to assess patient satisfaction with community pharmacists. In: American Pharmaceutical Association Annual Meeting, Mami, Florida, March 21–25. 1998.
